InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,979.70
(
0.85%
)
US TECH 100
20,560.40
(
1.67%
)
Dow Jones
43,780.87
(
0.12%
)
Brent Oil
75.39
(
0.42%
)
Bitcoin
76,703.25
(
1.40%
)
Post# of 19309
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120679
Boards Moderated 13
Alias Born 09/05/2002

DewDiligence

Member Level

Re: kris_kade post# 4556

Saturday, 08/11/2007 4:03:36 PM

Saturday, August 11, 2007 4:03:36 PM

Post# of 19309
>The nearest catalyst for GTCB is rates for reimbursement in EU countries which might give better insight into revenues down the road.<

I think it’s a mistake to consider the HD indication in Europe as more than a proof of concept for the platform. Revenues for GTC from this program in 2007 and 2008 are not going to be enough to affect the bottom line greatly.

Much bigger catalysts will be: 1) The reporting of top-line data from the US ATryn trial, which will happen in a few months; and 2) Inking a US ATryn partnership, which could happen at any time. Regards, Dew

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up